Literature DB >> 27886031

Pertussis in north-central and northwestern regions of Algeria.

Nabila Benamrouche1, Hassiba Tali Maamar, Malika Lazri, Sonia Hasnaoui, Abdelkarim Radoui, Ourida Lafer, Rachida Boukari, Chawki Kaddache, Zakia Arrada, Kheira Rahal.   

Abstract

INTRODUCTION: Pertussis outbreaks continue to occur in many countries despite high vaccination coverage. Under-diagnosed cases in adolescents and adults may result in increased transmission to infants, who are at risk of severe pertussis. Additional measures to protect both groups should be considered.
METHODOLOGY: Nasopharyngeal samples and sera were collected from patients and household contacts with clinically suspected pertussis. Diagnoses were confirmed by culture, real-time polymerase chain reaction (PCR), and serology. Bordetella pertussis isolates were characterized by antimicrobial sensitivity and fimbrial serotyping.
RESULTS: Of 392 participants, 134/248 patients (54%) and 66/144 contacts (45.8%) had confirmed pertussis infections. B. parapertussis was not detected. All B. pertussis isolates were sensitive to the antibiotics tested, and all expressed the Fim3, not the Fim2, fimbrial serotype. Most patients (81.2%) were <6 months (51.8% of whom were <3 months) of age; 77.6% were unvaccinated, and most positive contacts were mothers 20-40 years of age.
CONCLUSIONS: Despite high vaccination coverage, pertussis is circulating in Algeria. Most infections occur in unvaccinated infants <6 months of age, with mothers as the main source of infection. An adolescent/adult booster should be considered. Adoption of sensitive and specific laboratory tests would improve pertussis diagnosis and surveillance.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27886031     DOI: 10.3855/jidc.7262

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  5 in total

1.  Pertussis Reinfection in an Adult: A Cause of Persistent Cough Not to Be Ignored.

Authors:  Theocharis Koufakis; Anastasia Paschala; Dimitrios Siapardanis
Journal:  Case Rep Infect Dis       Date:  2017-07-13

2.  Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria.

Authors:  Khedidja Tahar Djebbar; Mounia Allouache; Salim Kezzal; Fouzia Benguerguoura; Chafia TouilBoukoffa; Ines Zidi; Rachida Raache; Hadda-Imene Ouzari
Journal:  Vaccines (Basel)       Date:  2022-06-06

3.  Immune responses to vaccine-preventable diseases among toddlers and preschool children after primary immunization and first booster in Northwestern Algiers, Algeria.

Authors:  Nabila Benamrouche; Hassiba Tali Maamar; Samia Chemli; Houria Senouci; Kheira Rahal
Journal:  Heliyon       Date:  2018-06-26

4.  The burden of laboratory-confirmed pertussis in low- and middle-income countries since the inception of the Expanded Programme on Immunisation (EPI) in 1974: a systematic review and meta-analysis.

Authors:  Rudzani Muloiwa; Benjamin M Kagina; Mark E Engel; Gregory D Hussey
Journal:  BMC Med       Date:  2020-08-28       Impact factor: 8.775

Review 5.  Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Africa.

Authors:  Denis Macina; Keith E Evans
Journal:  Infect Dis Ther       Date:  2021-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.